Navigation Links
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Date:9/27/2010

BOTHELL, Wash., Sept. 27 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE AMEX: DDD) today announced that Carl Johnson has been appointed as the Chairman of its Board of Directors.  Johnson succeeds Michael Taglich, who will remain a member of the Board.  

Johnson previously served as President and Chief Executive Officer of Matrixx Initiatives, Inc. Under Johnson's leadership, Matrixx successfully developed and launched the Zicam® product line. Johnson also has served as Vice President, Commercial Development, for Perrigo Company and before that was with Johnson & Johnson in both the consumer and professional healthcare products divisions.  Johnson was elected a director of SCOLR at its annual meeting in June.

Johnson said:  "I am greatly honored to have the opportunity to serve as Chairman of a company with the enormous potential of SCOLR.  Our unique technology gives us the opportunity to develop and market extended release nutritional and over-the-counter drug products that we believe will provide significant benefit to the consumer, and prove to be desirable in the marketplace."Taglich, SCOLR's outgoing Chairman, said: "In the short time that he has been a member of the Board, Carl's active involvement with management, and his industry expertise have greatly impressed the Board. With SCOLR's focus on the successful commercialization of our unique proprietary products, our shareholders are best served by Board leadership with experience in successfully bringing consumer products to market. Carl's professional successes in this area are impressive and we look forward to his contributions as Chairman."

Mr. Taglich added: "The Board's depth of experience in the consumer product market has also been strengthened by the recent addition of Marylou Arnett, who is currently the COO of Scerene Healthcare. Before co-found
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
2. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
3. SCOLR Pharma, Inc. Licenses Dietary Supplements
4. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
5. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
6. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
7. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
8. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA® Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
10. Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing
11. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013 More ... cancer may not benefit from chemotherapy and still have ... the launch of one of the largest sources of ... new website and interactive Facebook page provide recently diagnosed ... they can safely avoid chemotherapy. "We anticipate ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
(Date:5/23/2013)... Texas , May 23, 2013  Texas, premier ... to deliver doctors the survival tools they need to ... compete in today,s health care marketplace. "I ... will save local practices," said Stephen L. ... Association (TMA). " Texas doctors are ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... Qmed .com , the world,s only 100% ... engine, and central industry resource, today announced a ... ground-breaking detailed reports of industry-related adverse events, ... http://photos.prnewswire.com/prnh/20120423/LA91769LOGO )   (Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ...
... BEACH, Fla., April 23, 2012  SurgLine International, Inc. ... International, Inc. ("SGLN") and SurgLine, Inc. ("SurgLine") stated ... SurgLine has formed SurgLine MDC Holdings, LLC. ("SMDC"), ... owned subsidiary.  SMDC will be forming  joint-venture opportunities ...
Cached Medicine Technology:Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 2Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 3Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 4SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies 2
(Date:5/23/2013)... May 23, 2013 Live ... contemporary services, provides the best business lead solution ... Its Call center Management solution features Free Web ... Call Limitation, Do-Not-Call Maintenance and "Automatic Transfer Retry". ... comprehensive campaign delivery and management system. , Its ...
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... poor prognosis, with limited treatment options. In some ... it,s supposed to. New research from Western University explains ... identifies a mechanism to rectify that. ... team at Western,s Schulich School of Medicine & Dentistry, ... the death of cancer cells by binding to and ...
(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... products manufactured by C.R. Bard, Inc., continue to move ... District Court, Southern District of West Virginia, Bernstein Liebhard ... 17th, the Court denied a request by C.R. Bard ... claimed would reveal trade secrets and other confidential, proprietary ...
(Date:5/23/2013)... 2013 Former United States Vice President ... Acadian 's annual Paramedic Luncheon. , In front ... Cheney praised Acadian's medics, saying, "I am delighted to ... awarding the Paramedic of the Year Award. I think ... lot of competition within a company like this because ...
Breaking Medicine News(10 mins):Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2
... which is ill-equipped to cope, say experts. The amount of ... and rising, suggests health data. ,India has a population of ... developing diabetes later in life, and are certainly more vulnerable ... coronary heart disease. ,Part of the blame falls ...
... is bad for health. ,It seems that smokers have a ... heart disease in their blood. The discovery could help explain ... attacks than non-smokers. ,Paraoxonase is a enzyme which ... blood vessels. A team of Swiss researchers examined 367 people ...
... weapons go, anthrax is nowhere as terrifying as several others, ... University. Smallpox would be a lot worse. The government now ... Experiments are getting underway to see whether it can be ... still be effective. // ,“Anthrax is not ...
... less than 1mm in diameter, presents a new opportunity for ... Hollywood film technicians who worked alongside Dr Nicolas Beechey-Newham and ... at Guy’s Hospital in London to produce the “micro-camera”. ... the opening in a nipple – is able to view ...
... efficacy of a malaria drug are being questioned by ... be withdrawn. Manufacturer GlaxoSmithKline markets the anti-malarial drug Malarone ... at preventing the aggressive falciparum strain of malaria, but ... the Consumers’ Association – says the evidence for this ...
... be more likely to create illness than the weapons themselves, ... result of panic caused by the news of anthrax attacks. ... the UK, US and Australia predicted that while bioweapons themselves ... is having a devastating effect. ,Already, there are ...
Cached Medicine News:Health News:Diabetes on the rise, 2Health News:All the more bad, 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: